BRUMEDINE
InactiveInactive since 24-07-2026; last annual accounts for fiscal year 2026. Dissolved and wound up in a single deed on 06-07-2026.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2026 annual accounts show negative equity and a net loss.
NBB · annual accounts 2026Equity per financial year
1920212223242526
2019 to 2026 · latest year €-1k
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 09-07-2026, 114 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
114 d early
2025
115 d early
2024
128 d early
2023
120 d early
2022
116 d early
2021
69 d early
2020
45 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2026, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-2.46M▼ 1,053,219%
2025 · €-233
2019: €26khighest in 8 years
2020: €-202▼ -101% vs 2019
2021: €-312▼ -54.9% vs 2020
2022: €-204▲ +34.7% vs 2021
2023: €-208▼ -1.9% vs 2022
2024: €5k▲ +2302% vs 2023
2025: €-233▼ -105% vs 2024
2026: €-2.46M▼ -1053219% vs 2025lowest in 8 years
2019 → 2026
Working capital
€-1k▲ 98.7%
2025 · €-88k
2019: €-92k
2020: €-92k▼ -0.2% vs 2019
2021: €-92k▼ -0.3% vs 2020
2022: €-92k▼ -0.2% vs 2021
2023: €-93k▼ -0.2% vs 2022lowest in 8 years
2024: €-88k▲ +4.9% vs 2023
2025: €-88k▼ -0.3% vs 2024
2026: €-1k▲ +98.7% vs 2025highest in 8 years
2019 → 2026
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20222023202420252026Trend
Equity€2.48M-€2.48M=€2.48M▲ 0.2%€2.48M=€-1k
2022: €2.48M
2023: €2.48M● -0.0% vs 2022
2024: €2.48M▲ +0.2% vs 2023highest in 5 years
2025: €2.48M● -0.0% vs 2024
2026: €-1k▼ -100% vs 2025lowest in 5 years
Operating result€-174-€-178▼ 2.2%€-391▼ 120%€-203▲ 48.0%€-2.46M▼ 1,213,230%
2022: €-174highest in 5 years
2023: €-178▼ -2.2% vs 2022
2024: €-391▼ -120% vs 2023
2025: €-203▲ +48.0% vs 2024
2026: €-2.46M▼ -1213230% vs 2025lowest in 5 years
Net result€-204-€-208▼ 1.9%€5k€-233€-2.46M▼ 1,053,219%
2022: €-204
2023: €-208▼ -1.9% vs 2022
2024: €5k▲ +2302% vs 2023highest in 5 years
2025: €-233▼ -105% vs 2024
2026: €-2.46M▼ -1053219% vs 2025lowest in 5 years
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €2.46M in 2026 against €203 in 2025; the loss grows and 2026 has the lowest result in the available series.
Key figures and ratios
EBITDA
€698k
Cash flow
€707k
Interest coverage
23278.49
Debt
€3k▼
2025 · €674k
Debt ≤ 1 year
€3k▼
2025 · €90k
Debt > 1 year
€0▼
2025 · €584k
Ratios withheld: a balance sheet total of €2k is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2026 against 2025 · 40 lines
Balance sheet
Code20252026
Assets
Total assets20/58€3.16M€2k▼
Formation expenses20€0€0=
Fixed assets21/28€3.16M€0▼
Intangible fixed assets21€3.16M€0▼
Tangible fixed assets22/27€0€0=
Plant, machinery and equipment23€0€0=
Furniture and vehicles24€0€0=
Current assets29/58€2k€2k▼
Cash at bank and in hand54/58€2k€2k▼
Deferred charges and accrued income490/1€80€80=
Equity and liabilities
Total equity and liabilities10/49€3.16M€2k▼
Equity10/15€2.48M€-1k▼
Contributions10/11€2.98M€2.98M=
Capital10€2.11M€2.11M=
Issued capital100€2.11M€2.11M=
Outside capital11€873k€873k=
Share premium1100/10€873k€873k=
Profit (loss) carried forward14€-526k€-2.98M▼
Investment grants15€27k€0▼
Provisions and deferred taxes16€9k€0▼
Deferred taxes168€9k€0▼
Amounts payable17/49€674k€3k▼
Amounts payable after more than one year17€584k€0▼
Financial debts170/4€584k€0▼
Amounts payable within one year42/48€90k€3k▼
Trade debts44€13k€3k▼
Suppliers440/4€13k€3k▼
Other amounts payable47/48€77k€0▼
Income statement
Code20252026
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€3.16M
Other operating charges640/8€203€422▲
Gross operating margin9900€0€699k▲
Operating profit (loss)9901€-203€-2.46M▼
Financial charges65/66B€30€30=
Recurring financial charges65€30€30=
Profit (loss) for the period before taxes9903€-233€-2.46M▼
Transfer from deferred taxes780-€9k
Profit (loss) for the period9904€-233€-2.46M▼
Profit (loss) for the period to be appropriated9905€-233€-2.46M▼
Appropriation of the result
Profit (loss) to be appropriated9906€-526k€-2.98M▼
Profit (loss) brought forward from the previous period14P€-525k€-526k=
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | - | - | €3.16M | - |
| Other operating charges640/8 | €174 | €178 | €391 | €203 | €422 | ▲ 108% |
| Gross operating margin9900 | €0 | €0 | €0 | €0 | €699k | - |
| Operating profit (loss)9901 | €-174 | €-178 | €-391 | €-203 | €-2.46M | ▼ 1,213,230% |
| Financial income75/76B | - | - | €5k | - | - | - |
| Recurring financial income75 | - | - | €5k | - | - | - |
| Non-recurring financial income76B | - | - | €5k | - | - | - |
| Financial charges65/66B | €30 | €30 | €30 | €30 | €30 | = |
| Recurring financial charges65 | €30 | €30 | €30 | €30 | €30 | = |
| Profit (loss) for the period before taxes9903 | €-204 | €-208 | €5k | €-233 | €-2.46M | ▼ 1,057,087% |
| Transfer from deferred taxes780 | - | - | - | - | €9k | - |
| Profit (loss) for the period9904 | €-204 | €-208 | €5k | €-233 | €-2.46M | ▼ 1,053,219% |
| Profit (loss) for the period to be appropriated9905 | €-204 | €-208 | €5k | €-233 | €-2.46M | ▼ 1,053,219% |
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €3.17M | €3.17M | €3.16M | €3.16M | €2k | ▼ 99.9% |
| Formation expenses20 | €0 | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | €3.16M | €3.16M | €3.16M | €3.16M | €0 | ▼ 100% |
| Intangible fixed assets21 | €3.16M | €3.16M | €3.16M | €3.16M | €0 | ▼ 100% |
| Tangible fixed assets22/27 | €0 | €0 | €0 | €0 | €0 | - |
| Plant, machinery and equipment23 | €0 | €0 | €0 | €0 | €0 | - |
| Furniture and vehicles24 | €0 | €0 | €0 | €0 | €0 | - |
| Current assets29/58 | €3k | €2k | €2k | €2k | €2k | ▼ 12.9% |
| Amounts receivable within one year40/41 | €80 | €80 | - | - | - | - |
| Other amounts receivable41 | €80 | €80 | - | - | - | - |
| Cash at bank and in hand54/58 | €3k | €2k | €2k | €2k | €2k | ▼ 13.5% |
| Deferred charges and accrued income490/1 | - | - | €80 | €80 | €80 | = |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €3.17M | €3.17M | €3.16M | €3.16M | €2k | ▼ 99.9% |
| Equity10/15 | €2.48M | €2.48M | €2.48M | €2.48M | €-1k | ▼ 100% |
| Contributions10/11 | €2.98M | €2.98M | €2.98M | €2.98M | €2.98M | = |
| Capital10 | €2.11M | €2.11M | €2.11M | €2.11M | €2.11M | = |
| Issued capital100 | €2.11M | €2.11M | €2.11M | €2.11M | €2.11M | = |
| Outside capital11 | €873k | €873k | €873k | €873k | €873k | = |
| Share premium1100/10 | €873k | €873k | €873k | €873k | €873k | = |
| Profit (loss) carried forward14 | €-530k | €-530k | €-525k | €-526k | €-2.98M | ▼ 467% |
| Investment grants15 | €27k | €27k | €27k | €27k | €0 | ▼ 100% |
| Provisions and deferred taxes16 | €9k | €9k | €9k | €9k | €0 | ▼ 100% |
| Deferred taxes168 | €9k | €9k | €9k | €9k | €0 | ▼ 100% |
| Amounts payable17/49 | €679k | €679k | €674k | €674k | €3k | ▼ 99.6% |
| Amounts payable after more than one year17 | €584k | €584k | €584k | €584k | €0 | ▼ 100% |
| Financial debts170/4 | €584k | €584k | €584k | €584k | €0 | ▼ 100% |
| Amounts payable within one year42/48 | €95k | €95k | €90k | €90k | €3k | ▼ 97.0% |
| Trade debts44 | €28k | €28k | €13k | €13k | €3k | ▼ 78.4% |
| Suppliers440/4 | €28k | €28k | €13k | €13k | €3k | ▼ 78.4% |
| Other amounts payable47/48 | €67k | €67k | €77k | €77k | €0 | ▼ 100% |
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-204 | €-208 | €5k | €-233 | €-2.46M | ▼ 1,053,219% |
| + Depreciation and write-downs630 | - | - | - | - | €3.16M | - |
| Operating cash flow (approximation) | €-204 | €-208 | €5k | €-233 | €707k | ▲ 303,550% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €-208 | €-421 | €-233 | €-238 | ▼ 2.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2027, expected by
2026
04-08
State Gazette act
End & cessationResignations: Theodoor Van Herck (director) and Alfons Docx (director) · Approval · Director discharge11 facts ▸
State Gazette act
End & cessation
Resignations: Theodoor Van Herck (director) and Alfons Docx (director) · Approval · Director discharge11 facts ▸
- General meeting, 06/07/2026
- Approval, goedkeuring van de jaarrekening
- Director discharge, BRUMEDINE
- Net-asset statement, 31/05/2026
- Dissolution, 06-07-2026
- Liquidation, geen vereffenaar aangesteld
- Director resignation, Theodoor Van Herck (director)
- Director resignation, Alfons Docx (director)
- Liquidation closure, definitieve afsluiting van de vereffening
- Director discharge, BRUMEDINE
- Asset transfer, overgang van activa aan vennoten in verhouding van hun aandelenbezit
09-07
NBB filing
Annual accounts filed
fiscal year 2026 · full schema
31-03
Financial
Weakest financial yearnet €-2.46M
Net result drops to €-2.46M, the lowest in the series.
2025
08-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2024
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
31-03
Financial
Back to profitnet €5k
Net result €5k after 4 loss-making years.
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
23-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
16-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2019
27-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
11-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
04-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 5 acts read
About the unread acts
Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
no sitting director, last change in 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
04-08-2026
Alfons Docx: Resigned as Director
04-08-2026
Theodoor Van Herck: Resigned as Director
Not every act has been read: a resignation may be missing here
4 of this company's 5 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Wommelgem
Ground area
1,659 m²
Building footprint
443 m²
Volume, LiDAR
3,954 m³
Parcel 11052D0100/00H004, Flanders · tallest building 15.1 m, ±3 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11052D0100/00H004 | Flanders | 1,659 m² | 1 · 443 m² | 15.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector and region
Abella Mar
BE 0740.524.031
Kapellen
ASTELLAS PHARMA EUROPE B.V
BE 0803.977.570
LEIDEN
Calluna Pharma
BE 0866.397.070
Hoogstraten
Dr. Lins - Dr. Dubois
BE 0871.844.215
Antwerpen
Elke Robbe
BE 0728.580.163
Zoersel
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 148 companies in sector 21100 we hold annual accounts for 108. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded13-07-2000
Fiscal year end31-03
Activities, NACEBEL 2025
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
Scores and ratios are computed by Checked and are not a credit decision.